This article provides comprehensive guidance on recognising, classifying, and coding Mounjaro-related adverse effects using WHO ICD-10 codes, alongside MHRA reporting requirements and clinical management considerations for UK practitioners
Research shows that while 50-60% of users experience gastrointestinal side effects initially, these are usually mild to moderate and transient
What you eat is a big part of that
[104] In the study conducted by Christensen and colleagues, patients were treated with Liraglutide for 522 months, and the treatment has effectively induced the weight loss of 711 kg
Diabetes Care 43 , 27852795 (2020)
A., GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity, JAMA Oncol, Dec